Brief: Repligen Announces Strategic Partnership With Novasign To Further Advance Bioprocessing Digitalization
31/07/2025 13:11
July 31 (Reuters) - Repligen Corp RGEN.O: REPLIGEN ANNOUNCES STRATEGIC PARTNERSHIP WITH NOVASIGN TO FURTHER ADVANCE BIOPROCESSING DIGITALIZATION REPLIGEN: WILL INVEST IN NOVASIGN TO HELP SCALE AND EXPAND OPERATIONS Source text: ID:nGNX4X01sp Further company coverage: RGEN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repligen
See all newsBrief: Repligen Announces $1 Billion Private Convertible Senior Notes Transaction
Repligen Corporation reports results for the quarter ended September 30 - Earnings Summary
Repligen Q3 revenue beats estimates on higher demand; lifts outlook
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Repligen Corp reports results for the quarter ended June 30 - Earnings Summary